Literature DB >> 7981724

Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and polymorphisms in the NF1 gene.

M Upadhyaya1, D J Shaw, P S Harper.   

Abstract

Neurobromatosis type 1 (NF1) is one of the commonest genetic disorders in humans. The gene for NF1 was cloned in 1990. The protein encoded by the gene (neurofibromin) has extensive sequence homology with GTPase-activating protein (GAP). Despite screening the whole coding region of the gene for large and medium size rearrangements and approximately 40% of the coding region of the gene for small alterations, only 45 germ-line mutations have been reported in more than 500 unrelated patients. Of these, 25 mutations involve small changes in the gene, of which 17 (68%) result in the formation of an inappropriate stop codon. A "hot spot" for mutations has not been identified. The high mutation rate at this locus and the general difficulty in identifying mutations are discussed. A complete understanding of the structure and function of the NF1 gene awaits further detailed studies of both naturally occurring and in vitro-generated mutations.

Entities:  

Mesh:

Year:  1994        PMID: 7981724     DOI: 10.1002/humu.1380040202

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  13 in total

1.  Confirmation of a double-hit model for the NF1 gene in benign neurofibromas.

Authors:  E Serra; S Puig; D Otero; A Gaona; H Kruyer; E Ars; X Estivill; C Lázaro
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  Characterization of Saccharomyces cerevisiae strains expressing ira1 mutant alleles modeled after disease-causing mutations in NF1.

Authors:  R Gil; J M Seeling
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

3.  A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein.

Authors:  Igor D'Angelo; Stefan Welti; Fabien Bonneau; Klaus Scheffzek
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

4.  A cytogenetic deletion, del(17)(q11.22q21.1), in a patient with sporadic neurofibromatosis type 1 (NF1) associated with dysmorphism and developmental delay.

Authors:  M Upadhyaya; S H Roberts; J Maynard; E Sorour; P W Thompson; M Vaughan; A O Wilkie; H E Hughes
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

5.  Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.

Authors:  Y Zhu; M I Romero; P Ghosh; Z Ye; P Charnay; E J Rushing; J D Marth; L F Parada
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

6.  Monozygotic twins discordant for neurofibromatosis 1.

Authors:  Lee Kaplan; Rosemary Foster; Yiping Shen; Dilys M Parry; Mary L McMaster; Melanie Collins O'Leary; James F Gusella
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

7.  Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.

Authors:  M H Cnossen; K G Moons; M P Garssen; N M Pasmans; A de Goede-Bolder; M F Niermeijer; D E Grobbee
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

Review 8.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

9.  Identification of a nonsense mutation at the 5' end of the TSC2 gene in a family with a presumptive diagnosis of tuberous sclerosis complex.

Authors:  R Vrtel; S Verhoef; K Bouman; M M Maheshwar; M Nellist; A J van Essen; P L Bakker; C J Hermans; M T Bink-Boelkens; R M van Elburg; M Hoff; D Lindhout; J Sampson; D J Halley; A M van den Ouweland
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

10.  Scanning the first part of the neurofibromatosis type 1 gene by RNA-SSCP: identification of three novel mutations and of two new polymorphisms.

Authors:  P Gasparini; L D'Agruma; G Pio de Cillis; P Balestrazzi; R Mingarelli; L Zelante
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.